Endo Int'l (ENDP) wins appeal to block generic versions of Fortesta - Bloomberg

October 14, 2016 9:41 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Endo Int'l (NASDAQ: ENDP) wins appeal to block generic versions of Fortesta, according o Bloomberg.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Litigation, Trader Talk

Add Your Comment